Freenome
Backed by
Raised $254M Series E on Feb 15, 2024
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.
Automation Service Engineer I
Brisbane, California · Posted on Jul 17, 2025
Senior Information Security Analyst II
Remote · Posted on Jul 11, 2025
Automation Engineer III
Brisbane, California · Posted on May 28, 2025
Future Consideration
Brisbane, California · Posted on May 28, 2025
Senior Director, Market Access
Brisbane, California · Posted on May 28, 2025
Senior Machine Learning Scientist
Brisbane, California · Posted on May 28, 2025
Explore similar companies to Freenome
OpenEvidence
The leading medical information platform.
Orchid
Helping couples have healthy babies.
Headlight
Online therapy and mental health services.
Silna
Make care your primary focus.
Tandem Health
Medical notes that write themselves.
Eternal
Longevity care for athletes.
Anterior
Lead your health plan into the future.
Tennr
The intelligent automation platform for healthcare ops.
Collate
Empowering life sciences development.